Article info
Coronary artery disease
Original article
Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients
- Correspondence to Dr Wassef Karrowni, Unity Point Clinic-St Luke's Hospital, 202 10th Street SE, Suite 225, Cedar Rapids, IA 52403, USA; wassef{at}hotmail.com
Citation
Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients
Publication history
- Received March 31, 2014
- Revised September 16, 2014
- Accepted October 3, 2014
- First published October 21, 2014.
Online issue publication
February 13, 2020
Article Versions
- Previous version (13 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions